公开(公告)号：US20230151063A1

公开(公告)日：2023-05-18

申请号：US16497178

申请日：2018-04-13

申请人： Valneva Austria GmbH

发明人： Urban Lundberg ,  Andreas Meinke ,  Abhijeet Nayak ,  Wolfgang Schüler

IPC分类号： C07K14/20 ,  A61K39/02 ,  A61K39/39 ,  A61P31/04

CPC分类号： C07K14/20 ,  A61K39/0225 ,  A61K39/39 ,  A61P31/04 ,  C07K2319/02 ,  C07K2319/90 ,  A61K2039/70

摘要： The present invention relates to an immunogenic polypeptide, a nucleic acid encoding the same, a pharmaceutical composition comprising the same and the immunogenic polypeptide, nucleic acid or pharmaceutical composition for use as a medicament, particularly a vaccine, or for use in a method of treating or preventing a Borrelia infection.

公开(公告)号：US12018054B2

公开(公告)日：2024-06-25

申请号：US16497178

申请日：2018-04-13

申请人： Valneva Austria GmbH

发明人： Urban Lundberg ,  Andreas Meinke ,  Abhijeet Nayak ,  Wolfgang Schüler

IPC分类号： A61K39/02 ,  A61K39/39 ,  A61P31/04 ,  C07K14/20 ,  A61K39/00

CPC分类号： C07K14/20 ,  A61K39/0225 ,  A61K39/39 ,  A61P31/04 ,  A61K2039/55505 ,  A61K2039/575 ,  A61K2039/70 ,  C07K2319/02 ,  C07K2319/90

摘要： The present invention relates to an immunogenic polypeptide, a nucleic acid encoding the same, a pharmaceutical composition comprising the same and the immunogenic polypeptide, nucleic acid or pharmaceutical composition for use as a medicament, particularly a vaccine, or for use in a method of treating or preventing a Borrelia infection.